Neurotensin and dopamine interactions

EB Binder, B Kinkead, MJ Owens, CB Nemeroff - Pharmacological reviews, 2001 - ASPET
Interactions between the classical monoamine neurotransmitter dopamine (DA) and the
peptide neurotransmitter neurotensin (NT) in the central nervous system (CNS) have now been …

Inflammation as a predictive biomarker for response to omega-3 fatty acids in major depressive disorder: a proof-of-concept study

…, AA Nierenberg, PJ Schettler, B Kinkead… - Molecular …, 2016 - nature.com
This study explores whether inflammatory biomarkers act as moderators of clinical response
to omega-3 (n-3) fatty acids in subjects with major depressive disorder (MDD). One hundred …

Functional connectivity of the subcallosal cingulate cortex and differential outcomes to treatment with cognitive-behavioral therapy or antidepressant medication for …

…, CL McGrath, KS Choi, B Kinkead… - American Journal of …, 2017 - Am Psychiatric Assoc
Objective: The purpose of this article was to inform the first-line treatment choice between
cognitive-behavioral therapy (CBT) or an antidepressant medication for treatment-naive adults …

Quetiapine: preclinical studies, pharmacokinetics, drug interactions, and dosing

CB Nemeroff, B Kinkead, J Goldstein - Journal of Clinical …, 2002 - psychiatrist.com
Quetiapine is a novel dibenzothiazepine atypical antipsychotic. Quetiapine shows affinity for
various neurotransmitter receptors including serotonin, dopamine, histamine, and …

Elevated cerebrospinal fluid substance p concentrations in posttraumatic stress disorder and major depression

…, JR Strawn, G Sanacora, B Kinkead… - American Journal of …, 2006 - Am Psychiatric Assoc
Objective: The authors tested the hypothesis that concentrations of the pain-transmitting
neuropeptide substance P are elevated in the CSF of patients with major depression or …

[HTML][HTML] Targeting norepinephrine in mild cognitive impairment and Alzheimer's disease

T Chalermpalanupap, B Kinkead, WT Hu… - Alzheimer's research & …, 2013 - Springer
The Alzheimer's disease (AD) epidemic is a looming crisis, with an urgent need for new
therapies to delay or prevent symptom onset and progression. There is growing awareness that …

Effects of patient preferences on outcomes in the Predictors of Remission in Depression to Individual and Combined Treatments (PReDICT) study

…, T Mletzko-Crowe, B Kinkead… - American Journal of …, 2017 - Am Psychiatric Assoc
Objective: The Predictors of Remission in Depression to Individual and Combined Treatments
[PReDICT] study aimed to identify clinical and biological factors predictive of treatment …

[HTML][HTML] Predictors of remission in depression to individual and combined treatments (PReDICT): study protocol for a randomized controlled trial

…, JF Cubells, MM Goodman, ME Kelley, B Kinkead… - Trials, 2012 - Springer
Background Limited controlled data exist to guide treatment choices for clinicians caring for
patients with major depressive disorder (MDD). Although many putative predictors of …

Massage therapy decreases cancer‐related fatigue: Results from a randomized early phase trial

B Kinkead, PJ Schettler, ER Larson, D Carroll… - Cancer, 2018 - Wiley Online Library
BACKGROUND Cancer‐related fatigue (CRF) is a prevalent and debilitating symptom
experienced by cancer survivors, yet treatment options for CRF are limited. In this study, we …

Neurotensin: role in psychiatric and neurological diseases

R Cáceda, B Kinkead, CB Nemeroff - Peptides, 2006 - Elsevier
Neurotensin (NT), an endogenous brain–gut peptide, has a close anatomical and functional
relationship with the mesocorticolimbic and neostriatal dopamine system. Dysregulation of …